ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients
Teodoro Vargas(Madrid Institute for Advanced Studies), Ana Ramı́rez de Molina(Madrid Institute for Advanced Studies), Marta Mendiola(Hospital Universitario La Paz), Juan Moreno‐Rubio(Hospital La Paz Institute for Health Research), Paloma Cejas(Dana-Farber Cancer Institute), Cristina Aguayo(Hospital Universitario La Paz), Susana Molina(Madrid Institute for Advanced Studies), Ricardo Ramos(Centre for Plant Biotechnology and Genomics), Isidro Machado(Fundación Instituto Valenciano de Oncología), Meritxell Gironella(Inserm), Ricardo Yayá(Fundación Instituto Valenciano de Oncología), Roberto Martín‐Hernández(Madrid Institute for Advanced Studies), Joan Maurel(Breast Cancer Research Foundation), Jesús Herránz(Madrid Institute for Advanced Studies), Carlos Fernández-Martos(Fundación Instituto Valenciano de Oncología), Guillermo Reglero(Madrid Institute for Advanced Studies), Jorge Aparicio(Hospital Universitari i Politècnic La Fe), Ana Custodio(Hospital Universitario La Paz), Alberto Risueño, Isabel Espinosa‐Salinas(Madrid Institute for Advanced Studies), Javier De Las Rivas(Universidad de Salamanca), David Ramos(Hospital Universitari i Politècnic La Fe), Jaime Feliú(Hospital Universitario La Paz), Emilio Burgos(Hospital Universitario Infanta Sofía), Margarita González‐Vallinas(Universidad de Valladolid)
Cited by 76
Related Papers
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
|PLoS Genetics|2014|459
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
|Cancer Discovery|2021|286
Human Gene Coexpression Landscape: Confident Network Derived from Tissue Transcriptomic Profiles
|PLoS ONE|2008|248
Cancer drug resistance induced by EMT: novel therapeutic strategies
|Archives of Toxicology|2021|220